Market News & Trends
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and…
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and…
Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells
Cell Design Labs, Inc. recently announced the issuance of U.S. Patent No. 9,587,020, titled Chimeric Antigen Receptor and Methods of Use Thereof. This patent, issued…
Mucodel Pharma Announces Patent Allowance for Co-Gel Buccal Naloxone
Mucodel Pharma LLC recently announced it has received a notice of allowance from the United States Patent and Trademark Office for its utility patent application…
Vtesse Completes Enrollment of Phase IIb/III Pivotal Clinical Trial
Vtesse, Inc. recently announced its registrational study of investigational drug VTS-270 in Niemann-Pick Type C1 disease (NPC) is fully enrolled. "Completing enrollment in the pivotal…
SG Lab & Toxikon Europe Sign Partnership Agreement
Italian Stevanato Group, through its laboratory SG Lab, has signed a partnership agreement with Toxikon Europe, the Belgian Contract Research Organization (CRO) to include extractables…
Roquette Announces Commitment to Provide New Product Offerings
New product offerings are low endotoxin, multi-compendial-grade materials for cell culture and biologic drug formulations. These products extend Roquette's commitment to helping customers save and…
MRC Technology Licenses Antibody to Newsummit Biopharma
MRC Technology recently announced it has licensed an antibody to Newsummit Biopharma, a leading China-based drug development process solutions provider, for development of a novel…
TiGenix Receives Positive Feedback From the FDA on Global Phase III Trial Protocol
TiGenix NV, an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platform of allogeneic stem cells, recently announced it has…
ObsEva Begins Phase III Clinical Program
ObsEva SA, a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and…
Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology
Intellia Therapeutics, Inc., a leading genome editing company focused on the development of potentially curative therapies, recently reported updated data showing increased levels of genome…
New Data Demonstrate Sandoz Proposed Biosimilar Has Equivalent Efficacy
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, recently presented data for its proposed biosimilar adalimumab (GP2017). The Phase III confirmatory…
Esperion Announces Initiation of Phase II Triplet Oral Therapy Study
Esperion Therapeutics, Inc., the lipid management company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated…
AB BioTechnologies Selects Vanrx Pharmasystems Aseptic Filling & Lyophilizer Loading Workcells
AB BioTechnologies (AB), a provider of contract development and manufacturing services for the pharmaceutical industry, has selected Vanrx Pharmasystems to provide aseptic filling and lyophilizer…
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of…
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of…
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America. ABITEC Corporation has…
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America. ABITEC Corporation has…
Avomeen Analytical Services Announces New CEO
Avomeen Analytical Services, a full-service independent analytical testing and product development laboratory based in Ann Arbor, MI, recently announced that Mark Harvill has been named…
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set…
